BioMed Research International / 2015 / Article / Fig 2

Research Article

Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD

Figure 2

Development of hypertensive proteinuria in Ang II/DOCA salt model of CKD in the C57BL/6 mouse. For all graphs, indicates a significant difference between two groups where . For (a)–(d), □ signifies pretreatment, whereas ■ signifies 21-day posttreatment with Ang II/DOCA. (a), (b) Changes in systolic and diastolic blood pressure in response to Ang II/DOCA. (c), (d) Total 24 h urinary protein and albumin excretion with Ang II/DOCA treatment. (e) Time-course development of proteinuria, expressed as total 24-hour protein excretion at days 7, 14, 18, and 21 posttreatment with Ang II/DOCA.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.